Mayer-Rokitansky-Küster-Hauser syndrome: a review of 245 consecutive cases managed by a multidisciplinary approach with vaginal dilators
Mayer-Rokitansky-Kuster-Hauser syndrome management by a multidisciplinary approach, including psychologists, results in no need for surgical intervention.
D. Keith Edmonds, F.R.C.O.G., Gillian L. Rose, F.R.C.O.G., Michelle G. Lipton, D.Clin.Psy., Julie Quek, R.N.
Volume 97, Issue 3 , Pages 686-690, March 2012
To understand the efficacy of vaginal dilators in the management of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome.
Retrospective sequential study.
Main Outcome Measure(s):
Functional vaginal length and sexual satisfaction.
Of the patients who completed the program, 232 (94.9%) achieved a successful vaginal length (defined as greater than 6 cm in length and maximum width throughout the vagina and especially at the apex) and sexual function. When the program was completed by all patients, 100% of patients were successful.
Vaginal dilator therapy is the treatment of first choice for creation of the vagina in MRKH syndrome, and the success rates suggest that surgery is rarely, if ever, required.